01 / Who we are

About

An independent resource for navigating ibogaine treatment decisions.

A steadier place to begin

Crossing Alder offers clear, evidence-aware information on ibogaine treatment options, safety considerations, legal contexts, and questions to ask. It supports people seeking to evaluate high-stakes choices without promoting any provider or treatment path.

Our purpose is to make the decision process easier to inspect: what is known, what is uncertain, what needs professional review, and what questions deserve a direct answer. The main resource overview is organized to help readers return to those distinctions as they consider their next step.

Our editorial approach

We use a careful, plain-language approach to information. Material is considered against registries, published literature, official sources, and clearly identified limits in the available record. When a claim needs context, we favor primary or institutional sources, such as the ClinicalTrials.gov study registry, rather than promotional language.

Evidence is not treated as a shortcut to certainty. Readers should be able to distinguish research from interpretation, and general information from individualized guidance. That approach is consistent with the National Library of Medicine’s role in providing access to biomedical literature records.

  • 01IndependenceWe do not promote clinics, providers, or a particular treatment path.
  • 02Safety awarenessRisk, uncertainty, and the need for qualified review are kept visible.
  • 03Plain languageWe aim for useful explanations without overstatement or unnecessary jargon.
  • 04Evidence contextSources and their limits matter as much as a conclusion.
  • 05Informed choiceInformation should support questions, not decide on someone’s behalf.

A practical structure for evaluating information

Questions before decisions

We organize information around the practical questions people and families may need to raise with qualified professionals.

Clear comparison tools

Our information pathways are designed to help readers sort topics without treating a checklist as a recommendation.

For people facing a consequential choice

Crossing Alder is for people considering ibogaine, their families, and others seeking to understand treatment safety, legality, and provider-evaluation questions. It is also for readers who want a more grounded way to examine claims before relying on them.

People may encounter directories such as ibogaine treatment location guides or research-focused material including Texas clinical trial information. We encourage readers to treat those materials as starting points for further verification, not as a substitute for individualized evaluation.

Information has limits. We state them plainly.

Crossing Alder is an independent information resource, not a clinic, medical provider, or licensed treatment center. Its content is not medical or legal advice and should not replace individualized guidance from qualified professionals.

We do not provide diagnosis, screening, treatment recommendations, or legal determinations. Readers looking across the wider conversation may also encounter general material on the psychedelic drug ibogaine; the same need for careful sourcing and professional guidance applies.

Explore information pathways